Vitreo Retinal Surgery PLLC

Vitreo Retinal Surgery PLLC was paid $27.76M by Medicaid between Jan 2018 and Dec 2024, across 28 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 51% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	23,155	$552K
2019	23,704	$2.75M
2020	21,794	$3.31M
2021	24,909	$4.03M
2022	42,169	$5.36M
2023	39,650	$6.56M
2024incomplete	29,617	$5.20M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J0178	Injection, aflibercept, 1 mg	51%	8,782	7,973	$14.10M
J2778	Injection, ranibizumab, 0.1 mg	17%	4,247	3,970	$4.85M
67028	Intravitreal injection of a pharmacologic agent	10%	45,644	40,823	$2.80M
92134		5.2%	71,698	63,397	$1.44M
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	4.2%	27,187	24,336	$1.16M
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	3.8%	1,455	1,269	$1.06M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	3.3%	15,351	13,920	$929K
J9035	Injection, bevacizumab, 10 mg	3.3%	19,806	17,427	$929K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	2,088	1,933	$173K
92250		<1%	5,728	4,748	$107K
92235		<1%	1,570	1,473	$91K
J3590	Unclassified biologics	<1%	68	49	$36K

16 more codes

99233	Hospital visit by a doctor, follow-up day (complex)	<1%	459	$30K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	298	$28K
67228		<1%	116	$19K
76512		<1%	69	$2K
92020		<1%	118	$2K
1036F		0%	41	$0.00
G9903	Patient screened for tobacco use and identified as a tobacco non-user	0%	41	$0.00
G8397	Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy	0%	14	$0.00
G8482	Influenza immunization administered or previously received	0%	39	$0.00
2024F		0%	17	$0.00
G9744	Patient not eligible due to active diagnosis of hypertension	0%	15	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	45	$0.00
4040F		0%	52	$0.00
2026F		0%	19	$0.00
5010F		0%	14	$0.00
2022F		0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPOFFENBERGER, GRETCHEN (CFO)